Bellevue Group AG Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001674546

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q2 2024 · 166 positions · Total reported value $6.15B · Top-10 concentration 40.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 61.0% · 17 new · 64 cut · 24 exited

Active Share (vs S&P 500): 94.1% · vs QQQ: 96.5% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +12.4% · vs SPY -2.4% · Prev Value $4.20B — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2024 13F filing, Bellevue Group AG disclosed 166 equity positions with a combined reported value of $6.15B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 40.0% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2024 were IONS ($393.69M), ARGX ($297.53M), VRTX ($278.17M). By sector, the heaviest allocations are Health Care 90.0%, Industrials 1.5%. Versus the prior quarter, allocation shifted toward Health Care (+3.7pp) and away from Other (-3.2pp).

Versus the prior quarter, Bellevue Group AG opened 17 new positions, trimmed 64 and fully exited 24, a turnover rate of 61.0% of positions. The portfolio's overlap with the prior quarter was 88% of names.

The largest new positions opened in Q2 2024 were EWTX ($25.74M), ALT ($3.99M), WAY ($3.23M).

Of the 24 positions fully exited versus the prior quarter, the largest were SWAV ($34.45M), PACB ($17.22M), SPY ($3.48M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2024)

  • EWTX EDGEWISE THERAPEUTICS INC · $25.74M
  • ALT ALTIMMUNE INC · $3.99M
  • WAY WAYSTAR HLDG CORP · $3.23M
  • NKE NIKE INC · $263.80K
  • KURA KURA ONCOLOGY INC · $205.90K
  • TEM TEMPUS AI INC · $175.00K
  • RARE ULTRAGENYX PHARMACEUTICAL IN · $164.40K
  • ARQT ARCUTIS BIOTHERAPEUTICS INC · $162.75K

Fully Exited (vs previous quarter)

  • SWAV SHOCKWAVE MED INC · prev qtr: $34.45M
  • PACB PACIFIC BIOSCIENCES CALIF IN · prev qtr: $17.22M
  • SPY STATE STR SPDR S&P 500 ETF T · prev qtr: $3.48M
  • BMY BRISTOL-MYERS SQUIBB CO · prev qtr: $1.27M
  • GDX VANECK ETF TRUST · prev qtr: $1.04M
  • VERV VERVE THERAPEUTICS INC · prev qtr: $387.78K
  • VRDN VIRIDIAN THERAPEUTICS INC · prev qtr: $334.44K · history
  • SMPL SIMPLY GOOD FOODS CO · prev qtr: $268.84K

Insider Transactions (Form 4)

Latest Bellevue Group AG buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Bellevue Group AG files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 148 positions worth $4.75B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 148 positions · $4.75B reported value (Q2 2026)
  • Top 10 holdings = 42.9% of reported value
  • Largest position: AMGN (AMGEN INC) at 6.5%
  • Average position size: $32.11M

Sector Tilt

  • Health Care 92.6%
  • Industrials 1.7%
  • Information Technology 0.4%
  • (classified holdings cover 95% of value)

Quarterly Activity

  • Q2 2026: 17 new, 39 added, 64 reduced, 24 exited
  • 28 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 90.0%
Technology 0.7%
Other 6.9%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 8.26M $393.69M 6.40%
6.40%
Hold
2 691.87K $297.53M 4.83%
4.83%
Reduce
3 593.46K $278.17M 4.52%
4.52%
Reduce
4 1.90M $261.39M 4.25%
4.25%
Reduce
5 539.90K $240.18M 3.90%
3.90%
Reduce
6 919.83K $223.52M 3.63%
3.63%
Hold
7 2.57M $197.88M 3.21%
3.21%
Reduce
8 5.03M $195.18M 3.17%
3.17%
Reduce
9 545.93K $185.75M 3.02%
3.02%
Add
10 1.56M $185.69M 3.02%
3.02%
Reduce
11 2.47M $169.26M 2.75%
2.75%
Reduce
12 3.88M $167.29M 2.72%
2.72%
Reduce
13 1.61M $166.90M 2.71%
2.71%
Add
14 1.27M $143.84M 2.34%
2.34%
Add
15 2.15M $130.55M 2.12%
2.12%
Hold
16 1.26M $116.43M 1.89%
1.89%
Add
17 2.97M $109.98M 1.79%
1.79%
Add
18 205.68K $104.74M 1.70%
1.70%
Add
19 435.42K $87.87M 1.43%
1.43%
Add
20 347.33K $81.18M 1.32%
1.32%
Reduce
21 1.00M $78.85M 1.28%
1.28%
Reduce
22 2.04M $70.84M 1.15%
1.15%
Add
23 1.02M $68.45M 1.11%
1.11%
Reduce
24 2.39M $63.64M 1.03%
1.03%
Hold
25 1.54M $62.18M 1.01%
1.01%
Reduce
26 3.91M $60.76M 0.99%
0.99%
Reduce
27 101.55K $55.03M 0.89%
0.89%
Add
28 282.05K $50.76M 0.82%
0.82%
Add
29 1.16M $48.96M 0.80%
0.80%
Add
30 449.08K $48.74M 0.79%
0.79%
Add
31 4.46M $48.49M 0.79%
0.79%
Hold
32 232.70K $48.07M 0.78%
0.78%
Add
33 93.36K $45.48M 0.74%
0.74%
Hold
34 49.67K $44.97M 0.73%
0.73%
Reduce
35 155.26K $42.40M 0.69%
0.69%
Reduce
36 9.94M $42.25M 0.69%
0.69%
Hold
37 516.53K $41.58M 0.68%
0.68%
Reduce
38 6.38M $41.58M 0.68%
0.68%
Add
39 7.89M $41.50M 0.67%
0.67%
Hold
40 669.05K $40.87M 0.66%
0.66%
Reduce
41 123.09K $40.69M 0.66%
0.66%
Add
42 521.02K $40.60M 0.66%
0.66%
Add
43 1.80M $40.52M 0.66%
0.66%
Reduce
44 252.32K $39.87M 0.65%
0.65%
Hold
45 8.52M $39.69M 0.65%
0.65%
Hold
46 122.30K $39.29M 0.64%
0.64%
Reduce
47 1.42M $39.25M 0.64%
0.64%
Reduce
48 1.15M $39.13M 0.64%
0.64%
Add
49 143.98K $34.76M 0.56%
0.56%
Reduce
50 397.37K $34.69M 0.56%
0.56%
Hold

FAQ

What did Bellevue Group AG buy in 2024-Q2?

In its 2024-Q2 13F filing, Bellevue Group AG reported 166 equity positions worth $6.15B in aggregate; its largest disclosed positions were IONS ($393.69M), ARGX ($297.53M), VRTX ($278.17M).

How large is Bellevue Group AG's portfolio?

Bellevue Group AG reported $6.15B of long equity holdings across 166 positions as of 2024-Q2. Top-10 holdings account for 40.0% of reported value.

What is Bellevue Group AG's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/bellevue-group-ag/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →